North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy

Neuromuscular Disorders

Volumn 20, Issue 11, 2010, Pages 712-716

  Mazzone, Elena ^a   Martinelli, Diego ^a   Berardinelli, Angela ^b   Messina, Sonia ^a,c   D'Amico, Adele ^d   Vasco, Gessica ^a   Main, Marion ^e   Doglio, Luca ^f   Politano, Luisa ^g   Cavallaro, Filippo ^c   Frosini, Silvia ^h   Bello, Luca ⁱ   Carlesi, Adelina ^d   Bonetti, Anna Maria ^d   Zucchini, Elisabetta ^j   Sanctis, Roberto De ^a   Scutifero, Marianna ^g   Bianco, Flaviana ^a   Rossi, Francesca ^k   Motta, Maria Chiara ^a   Sacco, Annalisa ^a   Donati, Maria Alice ^l   Mongini, Tiziana ^k   Pini, Antonella ^j   Battini, Roberta ^h   Pegoraro, Elena ⁱ   Pane, Marika ^a   Pasquini, Elisabetta ^c   Bruno, Claudio ^f   Vita, Giuseppe ^c   Waure, Chiara de ^b   Bertini, Enrico ^d   Mercuri, Eugenio ^a,e   more..

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f G GASLINI INSTITUTE   (Italy)

^g SECOND UNIVERSITY OF NAPLES   (Italy)

^h UNIVERSITY OF PISA   (Italy)

ⁱ UNIVERSITY OF PADOVA   (Italy)

^j MAGGIORE HOSPITAL   (Italy)

^k UNIVERSITY OF TURIN   (Italy)

^l UNIVERSITY OF FLORENCE   (Italy)

more..

Author keywords

6 Minute walk test; Duchenne muscular dystrophy; North star ambulatory assessment

Indexed keywords

DEFLAZACORT; PREDNISOLONE;

6 MINUTE WALK TEST; ADOLESCENT; ARTICLE; CHILD; DRUG INTERMITTENT THERAPY; DUCHENNE MUSCULAR DYSTROPHY; FUNCTION TEST; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; NORTH STAR AMBULATORY ASSESSMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; STEROID THERAPY;

CHILD; EXERCISE TEST; GAIT; HUMANS; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; PROSPECTIVE STUDIES; WALKING;

EID: 77957748915     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2010.06.014     Document Type: Article

References (27)

1. Brooke M.H., Griggs R.C., Mendell J.R., Fenichel G.M., Shumate J.B., Pellegrino R.J. Clinical trial in Duchenne dystrophy. The design of the protocol. Muscle Nerve 1981, 4:186-197.
2. Scott O.M., Hyde S.A., Goddard C., Dubowitz V. Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve 1982, 5:291-301.
3. Stuberg W.A., Metcalf W.K. Reliability of quantitative muscle testing in healthy children and in children with Duchenne muscular dystrophy using a hand-held dynamometer. Phys Ther 1988, 68:977-982.
4. Florence J.M., Pandya S., King W.M., et al. Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy. Phys Ther 1992, 72:115-122.
5. Kilmer D.D., Abresch R.T., Fowler W.M. Serial manual muscle testing in Duchenne muscular dystrophy. Arch Phys Med Rehabil 1993, 74:1168-1171.
6. Escolar D.M., Henricson E.K., Pasquali L., Gorni K., Hoffman E.P. Collaborative translational research leading to multicenter clinical trials in Duchenne muscular dystrophy: the Cooperative International Neuromuscular Research Group (CINRG). Neuromuscul Disord 2002, 12:S147-S154.
7. Mayhew J.E., Florence J.M., Mayhew T.P., et al. Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy. Muscle Nerve 2007, 35:36-42.
8. Russell D., Rosenbaum P., Cadman D., Gowland C., Hardy S., Jarvis S. The gross motor function measure: a means to evaluate the effects of physical therapy. Dev Med Child Neurol 1989, 31:341-352.
9. O'Hagen J.M., Glanzman A.M., McDermott M.P., et al. An expanded version of the Hammersmith functional motor scale for SMA II and III patients. Neuromuscul Disord 2007, 17:693-697.
10. Bérard C., Payan C., Hodgkinson I., Fermanian J. The MFM Collaborative Study Group. A motor function measure for neuromuscular diseases. Construction. and validation study. Neuromuscul Disord 2005, 15:463-470.
11. Bérard C., Payan C., Fermanian J., Girardot F. A motor function measurement scale for neuromuscular diseases-description and validation study. Rev Neurol (Paris) 2006, 162:485-493. Groupe d'Etude MFM.
12. Vignos P.J., Spencer G.E., Archibald K.C. Management of progressive muscular dystrophy in childhood. JAMA 1963, 184:89-96.
13. Main M., Kairon H., Mercuri E., Muntoni F. The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation. Eur J Paediatr Neurol 2003, 7:155-159.
14. Mercuri E., Mayhew A., Muntoni F., et al. On behalf of the TREAT-NMD Neuromuscular Network. Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; Report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th-13th May 2007, Naarden, The Netherlands; TREAT-NMD workshop on outcome measures in experimental trials for DMD, 30th June-1st July 2007, Naarden, The Netherlands; Conjoint Institute of Myology TREAT-NMD Meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France. Neuromuscul Disord 2008, 18:894-903.
15. Scott E., Eagle M., Main M., Sheehan J. The North Star Ambulatory Assessment. Abstract 31st annual meeting of the British Paediatric Neurology Association. 18th-20th January 2006. Dev Med Child Neurol 2006, 2006:27.
16. Eagle M, Scott E, Main M, et al. Steroids in Duchenne muscular dystrophy (DMD): natural history and clinical evaluation using the North Star Ambulatory Assessment (NSAA). Abstract World Muscle Society, Taormina, Italy 17- 20 October 2007, Neuromuscul Disord 2007;17:774.
17. Mazzone E.S., Messina S., Vasco G., et al. Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord 2009, 19(7):458-461.
18. McDonald C.M., Abresch R.T., Carter G.T., et al. Profiles of neuromuscular diseases. Duchenne muscular dystrophy. Am J Phys Med Rehabil 1995, 74:S70-S92.
19. Mcdonald CM, Henricson EK, Han JJ, et al. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve 2009 Nov 25.
20. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
21. Lammers A.E., Hislop A.A., Flynn Y., et al. The 6-minute walk test: normal values for children of 4-11 years of age. Arch Dis Child 2008, 93(6):464-468.
22. Kierkegaard M., Tollback A. Reliability and feasibility of the six minute walk test in subjects with myotonic dystrophy. Neuromuscul Disord 2007, 17:94-99.
23. Wokke J.H., Escolar D.M., Pestronk A., et al. Clinical features of late-onset Pompe disease: a prospective cohort study. Muscle Nerve 2008, 38:1236-1245.
24. Takeuchi Y., Katsuno M., Banno H., et al. Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. Muscle Nerve 2008, 38:964-971.
25. Novak P., Burger H., Marincek C. Meh D. Influence of foot pain on walking ability of diabetic patients.J Rehabil Med 2004, 36:249-252.
26. Mannerkorpi K., Svantesson U., Broberg C. Relationships between performance-based tests and patients' ratings of activity limitations, self-efficacy, and pain in fibromyalgia. Arch Phys Med Rehabil 2006, 87:259-264.
27. Biggar W.D., Harris V.A., Eliasoph L., Alman B. Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscul Disord 2006, 16:249-255.